{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:01:21Z","timestamp":1768323681691,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/olq.0b013e3182756efd","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T10:11:28Z","timestamp":1355825488000},"page":"28-31","source":"Crossref","is-referenced-by-count":38,"title":["Changes in Incidence of Anogenital Warts Diagnoses After the Introduction of Human Papillomavirus Vaccination in Germany\u2014An Ecologic Study"],"prefix":"10.1097","volume":"40","author":[{"given":"Rafael T.","family":"Mikolajczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela A.","family":"Kraut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Schulze-Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edeltraut","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210213","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2334-8-76","article-title":". Estimation of the incidence of genital warts and the cost of illness in Germany: A cross-sectional study.","volume":"8","author":"Hillemanns","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R2-6-20210213","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/sti.2009.040188","article-title":". Genital warts incidence and healthcare resource utilisation in Australia.","volume":"86","author":"Pirotta","year":"2010","journal-title":"Sex Transm Infect"},{"key":"R3-6-20210213","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajog.2008.03.064","article-title":"The economic burden of noncervical human papillomavirus disease in the United States.","volume":"198","author":"Hu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R4-6-20210213","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/sextrans-2011-050073","article-title":". The impact of genital warts: Loss of quality of life and cost of treatment in eight sexual health clinics in the UK.","volume":"87","author":"Woodhall","year":"2011","journal-title":"Sex Transm Infect"},{"key":"R5-6-20210213","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/sti.2010.048421","article-title":". Genital warts and cost of care in England.","volume":"87","author":"Desai","year":"2011","journal-title":"Sex Transm Infect"},{"key":"R6-6-20210213","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":". Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial.","volume":"341","author":"Dillner","year":"2010","journal-title":"BMJ"},{"key":"R8-6-20210213","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":". Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"R9-6-20210213","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":". Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"R12-6-20210213","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00112-009-2012-z","article-title":"Erste Erfahrungen zur Akzeptanz der HPV-ImpfungDurchimpfungsrate eines Jahrgangs in einer Grossstadt 1 Jahr nach Impfempfehlung durch die STIKO.","volume":"10","author":"Roggendorf","year":"2009","journal-title":"Monatsschrift Kinderheilkunde"},{"key":"R15-6-20210213","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":". Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: Analysis of national sentinel surveillance data.","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"R16-6-20210213","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":". Rapid decline in presentations for genital warts after the implementation of a national quadrivalent human papillomavirus vaccination program for young women.","volume":"85","author":"Fairley","year":"2009","journal-title":"Sex Transm Infect"},{"key":"R17-6-20210213","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","article-title":". The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme.","volume":"87","author":"Read","year":"2011","journal-title":"Sex Transm Infect"},{"key":"R18-6-20210213","first-page":"51","article-title":"Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.","volume":"124","author":"Oliphant","year":"2011","journal-title":"N Z Med J"},{"key":"R19-6-20210213","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","article-title":"Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: An analysis of California public family planning administrative claims data, 2007-2010.","volume":"102","author":"Bauer","year":"2012","journal-title":"Am J Public Health"},{"key":"R20-6-20210213","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1471-2334-10-360","article-title":". Incidence of anogenital warts in Germany: A population-based cohort study.","volume":"10","author":"Kraut","year":"2010","journal-title":"BMC Infect Dis"},{"key":"R21-6-20210213","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/pds.1545","article-title":"Establishment of a pharmacoepidemiological database in Germany: Methodological potential, scientific value and practical limitations.","volume":"17","author":"Pigeot","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R23-6-20210213","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model.","volume":"6","author":"Schwarz","year":"1978","journal-title":"Ann Stat"},{"key":"R24-6-20210213","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2249.2010.04268.x","article-title":". Monitoring of human papillomavirus vaccination.","volume":"163","author":"Dillner","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"R25-6-20210213","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1071\/SH09137","article-title":"Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: Towards a national HPV surveillance strategy.","volume":"7","author":"Brotherton","year":"2010","journal-title":"Sex Health"},{"key":"R26-6-20210213","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/jnci\/djr319","article-title":". Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV1618 vaccine.","volume":"103","author":"Kreimer","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R27-6-20210213","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","article-title":". Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: An ecological study.","volume":"377","author":"Brotherton","year":"2011","journal-title":"Lancet"}],"container-title":["Sexually Transmitted Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/OLQ.0b013e3182756efd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:56:45Z","timestamp":1620968205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007435-201301000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/olq.0b013e3182756efd","relation":{},"ISSN":["0148-5717"],"issn-type":[{"value":"0148-5717","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}